Related Experiment Video

Updated: May 18, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44

Kosuke Funato1, Yusuke Yamazumi, Takeaki Oda

  • 1Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.

Experimental and Therapeutic Medicine
|September 15, 2012
PubMed

Insights

Protein tyrosine phosphatase receptor type D (PTPRD) suppresses colon cancer cell migration and is crucial for cell adhesion. Its down-regulation correlates with increased cancer invasion and poorer patient survival, highlighting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Protein tyrosine phosphatase receptor type D (PTPRD) is frequently altered in various cancers.
  • The precise molecular functions of PTPRD in cancer progression remain largely unknown.

Purpose of the Study:

  • To investigate the role of PTPRD in colon cancer cell migration, adhesion, and invasion.
  • To elucidate the molecular mechanisms underlying PTPRD's function in colon cancer.

Main Methods:

  • Analysis of PTPRD's effect on colon cancer cell migration and cell-cell adhesion.
  • Investigation of PTPRD's interaction with β-catenin/TCF signaling and CD44.
  • Correlation of PTPRD expression levels with cancer invasiveness and patient survival.

Main Results:

  • PTPRD significantly suppressed colon cancer cell migration.
  • PTPRD is essential for proper cell-cell adhesion.
  • PTPRD regulates cell migration through β-catenin/TCF signaling and CD44.
  • Down-regulated PTPRD expression is observed in highly invasive cancers and correlates with reduced patient survival.

Conclusions:

  • PTPRD acts as a suppressor of colon cancer cell migration and invasion.
  • PTPRD plays a critical role in maintaining cell-cell adhesion.
  • Altered PTPRD expression is linked to colon cancer progression and patient prognosis.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...